Determinants of orphan drugs prices in France: a regression analysis

BACKGROUND: The introduction of the orphan drug legislation led to the increase in the number of available orphan drugs, but the access to them is often limited due to the high price. Social preferences regarding funding orphan drugs as well as the criteria taken into consideration while setting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Korchagina, Daria, Millier, Aurelie, Vataire, Anne-Lise, Aballea, Samuel, Falissard, Bruno, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399414/
https://www.ncbi.nlm.nih.gov/pubmed/28427466
http://dx.doi.org/10.1186/s13023-016-0561-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399414/
https://www.ncbi.nlm.nih.gov/pubmed/28427466
http://dx.doi.org/10.1186/s13023-016-0561-5

Ejemplares similares